Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines
Endemic and epidemic group A meningococcal meningitis remains a major cause of morbidity and mortality in sub-Saharan Africa, despite the availability of the safe and inexpensive group A meningococcal polysaccharide vaccine, which is protective at all ages when administered as directed. Despite opti...
Main Authors: | Robbins John B., Schneerson Rachel, Gotschlich Emil C., Mohammed Idris, Nasidi Abdulsalami, Chippaux Jean-Philippe, Bernardino Luis, Maiga Moussa A. |
---|---|
Format: | Article |
Language: | English |
Published: |
The World Health Organization
2003-01-01
|
Series: | Bulletin of the World Health Organization |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862003001000010 |
Similar Items
-
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023-08-01) -
Meningococcal meningitis C in Tamil Nadu, public health perspectives
by: Kirubah Vasandhi David, et al.
Published: (2014-01-01) -
Microbiological and Serological Evaluation of the Meningitis Outbreak in a Community Center in Isfahan Province, Iran, during the Years 2016-2017
by: Reza Khadivi, et al.
Published: (2018-04-01) -
Primary immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2008–2017
by: Xinren Che, et al.
Published: (2021-04-01) -
Association between Meningococcal Meningitis and Santa Ana Winds in Children and Adolescents from Tijuana, Mexico: A Need for Vaccination
by: Enrique Chacon-Cruz, et al.
Published: (2023-02-01)